Crossmark

HER3 targeting with an antibody‐drug conjugate bypasses resistance to anti‐HER2 therapies

Crossref DOI link: https://doi.org/10.15252/emmm.201911498

Published Online: 2020-04-24

Published Print: 2020-05-08

Update policy: https://doi.org/10.1002/crossmark_policy

Authors

Gandullo‐Sánchez, Lucía

Capone, Emily

Ocaña, Alberto

Iacobelli, Stefano

Sala, Gianluca https://orcid.org/0000-0002-4494-915X
Pandiella, Atanasio https://orcid.org/0000-0002-4704-8971
Funding

Funding for this research was provided by:

Ministerio de Economía y Competitividad (BFU2015‐71371‐R, BES‐2016‐077748)

Instituto de Salud Carlos III (RD12/0036/0003)

Fundación Científica Asociación Española Contra el Cáncer
License Information

Version of Record valid from 2020-04-24
More Information

Publication History

Received: 2019-09-24

Accepted: 2020-03-29

Published: 2020-04-24